Domain Associates — Full Portfolio
21 tracked investments · listed companies and verified rows first
Aldeyra develops medicines for immune-mediated diseases, with product candidates aimed at inhibiting inflammatory cells linked to ocular and systemic conditions.
BiotechMedical DevicesLexington, US
Todd C. Brady(Executive Officer, Director)Stephen Tulipano(Executive Officer)Scott L. Young(Executive Officer)
BoardJesse I. Treu(Director)inBen Bronstein(Director)Gary Phillips(Director)
Board seatJesse Treu· per SEC Form D · $18.4M raise · filed Jan 2015
BiotechSan Diego, US
Han Cao(Executive Officer)Gulsen Kama(Executive Officer)Mark Oldakowski(Executive Officer)Jonathan Dixon(Executive Officer)R. Erik Holmlin(Executive Officer, Director)Alka Chaubey(Executive Officer)
Board seatBrian Halak· per SEC Form D · $68.4M raise · filed Jan 2015
BiotechSan Diego, US
Ivy Zhang(Executive Officer)Saundra Pelletier(Executive Officer, Director)Kelly Culwell(Executive Officer)Justin J. File(Executive Officer)Alexander A. Fitzpatrick(Executive Officer)Russell Barrans(Executive Officer)
Board seatKim Kamdar· per SEC Form D · $25M raise · filed May 2020
Sera Prognostics develops women's health diagnostics focused on pregnancy, including the PreTRM blood test that predicts an individual's risk of spontaneous preterm birth in singleton pregnancies and the LikeMine platform that compares pregnancy outcomes using U.S. pregnancy data.
BiotechDigital HealthFemTechHealthtechSalt Lake City, US
Douglas Fisher(Executive Officer)Jay Moyes(Executive Officer)Gregory C. Critchfield(Executive Officer, Director)Andrew A. Sauter(Executive Officer)
BoardMansoor Mirza(Director)Ryan M. Trimble(Director)
Co-investorsaMoonExcelestar VenturesOUP (Osage University Partners)UpStart VenturesVivo CapitalCatalyst Health Ventures
Aspen Neuroscience develops iPSC-derived autologous cell therapies for neurological diseases, with a lead product (ANPD001) in Phase 1/2a clinical trials for Parkinson's disease.
BiotechDeep TechDigital HealthMedical Devices
Andrés Bratt-Leal(Co-Founder and Senior Vice President, Research & Development)Damien McDevitt(President and Chief Executive Officer)
Co-investorsARCH Venture PartnersLifeforce CapitalOrbiMedEDB InvestmentsSection 32Frazier Life Sciences+3 more
Truvian builds an on-site blood diagnostics platform that combines clinical chemistry, immunoassay, and hematology testing in a single compact instrument.
BiotechDigital HealthMedical DevicesSan Diego, US
Dena Marrinucci(Co-Founder & Chief Operating Officer)inMichael J. Mina(Chief Medical and Strategy Officer)
Co-investorsDns CapitalGreatPoint VenturesWittington VenturesMedical Excellence CapitalOS Fund
BiotechSan Mateo, US
Anthony Ford(Executive Officer)Michael Kitt(Executive Officer)Kathleen Sereda Glaub(Executive Officer, Director)
BoardKevin Starr(Director)inArthur Pappas(Director)Liam Ratcliffe(Director)
Board seatJesse Treu· per SEC Form D · $55M raise · filed Jul 2015
Co-investorsPappas CapitalThird Rock Ventures
BiotechDurham, US
Bernice Kuca(Executive Officer)Mathers P. Thomas(Executive Officer, Director)Nadia Rupniak(Executive Officer)Timothy C. Gupton(Executive Officer)
BoardJesse I. Treu(Director)inRichard J. Markham(Director)
Board seatJesse Treu· per SEC Form D · $37.1M raise · filed Jan 2015
Co-investorsPappas CapitalTVM Capital
BiotechBellevue, US
Michael Gertner(Executive Officer, Director)
BoardLouis Cannon(Director)Christopher Shen(Director)Immanuel Thangaraj(Director)Henry A. Plain, Jr.(Director)
Board seatBrian Halak· per SEC Form D · $22.4M raise · filed Sep 2015
Co-investorsLightstone Ventures
Currax Pharmaceuticals develops and markets a portfolio of therapies for chronic progressive diseases.
BiotechHealthtechLa Jolla, US
Preston Klassen(Executive Officer)Joseph Hagan(Executive Officer)Michael Narachi(Executive Officer, Director)Thomas Cannell(Executive Officer)
BoardBrian H. Dovey(Director)in
Board seatBrian DoveyEckard Weber· per SEC Form D · $90M raise · filed Sep 2015
Co-investorsCross Creek AdvisorsNew Enterprise Associates (NEA)Sofinnova VenturesDomain Partners
HealthtechDuluth, US
Anthony V. Lando(Executive Officer, Director)Todd Meyer(Executive Officer)Dilip Paithanker(Executive Officer)Robert Leslie(Executive Officer)Todd Brady(Director)Dilip Paithankar(Executive Officer)
Board seatJesse Treu· per SEC Form D · $15M raise · filed Sep 2019
SonoThera is developing a nonviral, non-invasive gene delivery technology that uses ultrasound and microbubbles (ultrasound-mediated delivery) to deliver genetic payloads to targeted sites in a redosable way.
BiotechDeep TechHealthtechSouth San Francisco, US
Kenneth Greenberg(Co-Founder, President & CEO)in
Board seatBrian Halak· per SEC Form D · $125.5M raise · filed Jun 2026
Co-investorsVida VenturesLeaps by BayerFoothill VenturesIllumina VenturesMedical Excellence CapitalVivo Capital+1 more
BiotechCarlsbad, US
Thomas M. Estok(Executive Officer, Director)Tracy Parrott(Executive Officer)Dennis Bilski(Executive Officer)
BoardEvgeny Zaytsev, M.D.(Director)Alain Schreiber(Director)
Board seatKim KamdarEckard Weber· per SEC Form D · $1.2M raise · filed Jul 2015
Biopharmaceutical developer of tumor-selective PARP inhibitor cancer therapies, acquired by Sanofi-aventis in 2009.
Co-investorsAisling CapitalAsset Management CompanyCanaan PartnersKleiner PerkinsSPRINGROCK VENTURESVantagePoint Capital Partners
ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.
AI & Machine LearningBiotechHealthtechMedical DevicesCarlsbad, US
Paul Flook(Executive Officer, Director)Gregory J. Gosch(Executive Officer, Director)Lynne Rollins(Executive Officer)Aditya Rajagopal(Director)Axel Scherer(Director)
BoardJustin Klein(Director)in
Co-investorsAdjuvant CapitalGlobal BrainMoore Venture PartnersNew Enterprise Associates (NEA)Windham Capital PartnersDomain Partners+2 more
Colorescience is a professional skincare brand that develops mineral-based sun protection (SPF), skincare, and color correction products, originally created for post-procedure skin and marketed for all ages and skin types.
ConsumerDirect to ConsumerHealthtechWellness & FitnessCarlsbad, US
Stephen Loomis(Executive Officer)Mary Fisher(Executive Officer, Director)Theodore Ebel(Executive Officer)Lynelle Lynch(Director)Howard D. Palefsky(Director)Brian H. Dovey(Director)
Co-investors1315 CapitalAisling CapitalHealthCare Ventures, LLCLongwood FundRoundTable Healthcare PartnersSplit Rock Partners
GenVault operates a GxP-compliant biorepository providing secure, temperature-controlled storage, sample management, and lab relocation services for biological, clinical, and biopharmaceutical materials.
BiotechHealthtechLogistics & Supply Chain
Co-investorsCross Creek Advisors
Locus Biosciences develops engineered bacteriophage therapies for treating bacterial infections and conditions in immunology, oncology, and CNS disorders.
AI & Machine LearningBiotechDeep TechHealthtechRaleigh, US
Paul Garofolo(CEO & Co-founder)NICK TAYLOR(Executive Officer)PAUL GAROFOLO(Executive Officer, Director)Nick Conley(Vice President of Technology (Co-founder of EpiBiome, acquired by Locus))
BoardGEOFFREY GLASS(Director)DAVID JOHNSTON(Director)
Co-investorsArtis VenturesAbstract VenturesHemisphere Ventures LLCLongitude CapitalStarlight Ventures
BiotechRadnor, US
Scott Braunstein, MD(Executive Officer, Director)Edward F. Smith(Executive Officer)Joe Hulihan, MD(Executive Officer)
BoardNicole Vitullo(Director)Enrique J. Carrazana, MD(Director)Michael R. Dougherty(Director)
Co-investorsAvoro Capital AdvisorsBain Capital Life SciencesCanaan PartnersConnecticut InnovationsSofinnova VenturesFlare Capital Partners+1 more
San Diego DNA sequencing company behind the Sequencing by Binding short-read platform; acquired by Pacific Biosciences in 2021.
Co-investorsARCH Venture PartnersDecheng CapitalALTITUDE LIFE SCIENCE VENTURESHillhouse CapitalNan Fung Life Sciences
Thermo Fisher provides life science products and laboratory equipment, including antibodies, consumables, biobanking resources, and Cryo-EM imaging systems for research labs and scientists.
BiotechEnterprise SoftwareHardwareHealthtechWaltham, US
Marc N. Casper(Executive Officer, Director)Andrew J. Thomson(Executive Officer)Peter M. Wilver(Executive Officer)Seth H. Hoogasian(Executive Officer)Alan J. Malus(Executive Officer)Edward A. Pesicka(Executive Officer)
Co-investorsARCH Venture PartnersBayMed Venture PartnersCross Creek AdvisorsExcel Venture ManagementHeran PartnersOak HC/FT+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.